Metraipolis › archive › dc_fea90d005f21
Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients — Europe PMC PMID:42278363
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42278363
- DOI
- 10.3390/ijms27114832
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:56:53.894Z
- SHA-256 of the archived text
54fcb2bd27dce4ae8c73538e1a4013c23e135fb58ce729b277dea3a1bdb0507d- Stable URL of this page
https://metraipolis.com/documento/dc_fea90d005f21
How to cite
Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients — Europe PMC PMID:42278363 — Europe PMC (en), https://europepmc.org/article/MED/42278363 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fea90d005f21 (Metraipolis archive dc_fea90d005f21, sha256 54fcb2bd27dce4ae8c73538e1a4013c23e135fb58ce729b277dea3a1bdb0507d)
BibTeX
@misc{dcfea90d005f21,
title = {Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients — Europe PMC PMID:42278363},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42278363},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fea90d005f21; sha256 54fcb2bd27dce4ae8c73538e1a4013c23e135fb58ce729b277dea3a1bdb0507d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42278363. Agents can read the archived copy with the MCP tool read_document.